The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips.
The deal covers Canon BioMedical's Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.
Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.
The method uses chitosan-coated magnetic beads and bead-based lysis to reduce the number of sample prep steps.
The companies have been working together since early 2015 on a diagnostic for the early detection of Lyme disease.
The firm has launched genotyping assays that rely on PCR followed by high-resolution melt analysis, as well as master mix companion chemistry.
The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.
Among Canon BioMedical's life science projects is a genetic testing platform based on ultra-fast serial PCR and high-resolution melt analysis.
The partners will work together to build a rapid diagnostic test panel for Lyme Disease using T2's magnetic resonance detection technology.
Beckman Coulter has been awarded
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.